Search
for
Sort by
Research 30 of 1000+
- Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C
- Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
- Alopecia areata during Interferon Alpha-2b/Ribavirin Therapy
- Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling
- Effect of interferon therapy on quality of life in patients with chronic hepatitis B
- Alopecia universalis as a side effect of pegylated interferon α-ribavirin combination therapy for hepatitis C: a rare case report
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege
- Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
- Multiple sclerosis: Side effects of interferon beta therapy and their management
- Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon α 2a therapy for chronic hepatitis C virus infection
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C
- Clinical Characteristics and Factors Associated with Hair Loss Severity in Chronic Hepatitis B Patients Receiving Pegylated Interferon-Alpha: A Retrospective Cohort Study
- Widespread Dystrophic-Anagen Alopecia and Drug Eruption due to Usage of PEG-IFN ?-2a /Ribavirin Combination Therapy
- Intralesional therapy for the treatment of keratoacanthoma
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Dermatologic therapy: December 1986 to December 1987
- Cutaneous reactions to recombinant cytokine therapy
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Assessment of Cytokine-Mediated Signaling Pathway Dysregulation in Arm Skin After CO2 Laser Therapy
- THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES
- 478 Mutation-specific siRNA Knockdown of GJB2 − Potential gene therapy for Keratitis-ichthyosis-deafness Syndrome
- Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application
- Straight hair associated with interferon-alfa plus ribavirin in hepatitis C infection
- Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models
- Intrinsic Modulators of Hair Growth: Roles of Growth Factors, Cytokines, Chemokines, and Interferons
- Alopecia areata: from pathophysiology to therapeutic innovation
- Paradoxical reactions in the era of modern biological therapy of psoriasis — a comprehensive analysis of pathomechanisms and clinical guidelines